Arca Biopharma reported $4.09M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Arca Biopharma USD 4.09M 441K Mar/2025
Biogen USD 31.6M 700K Sep/2025
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Cytokinetics USD 10.25M 2.75M Sep/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Myriad Genetics USD 300K 0 Mar/2025
Otsuka Holdings JPY 10.49B 396M Jun/2024
Pfizer USD 0.62 156M Sep/2025
United Therapeutics USD 46.4M 4.9M Sep/2025